Loose Maria, Naber Kurt G, Coates Anthony, Wagenlehner Florian M E, Hu Yanmin
Clinic for Urology, Pediatric Urology and Andrology, Justus-Liebig University Giessen, Giessen, Germany.
Department of Urology, Technical University of Munich, Munich, Germany.
Front Microbiol. 2020 Jan 29;11:54. doi: 10.3389/fmicb.2020.00054. eCollection 2020.
Antimicrobial susceptibility testing (AST) performed according to defined guidelines is important to identify resistance and to predict the clinical success or failure of specific antibiotic therapy. However, these guidelines do not cover all physiological conditions that can have a tremendous impact on resistance. In this study, we tested the susceptibility of thirteen positive strains against colistin, one of the last resort antibiotics for treating multi-drug resistant pathogens, in media recommended for ASTs as well as - physiologically more relevant - in human serum and artificial urine (AU). Minimal inhibitory concentration (MIC) values in heat-inactivated human serum were similar to those in cation-adjusted Mueller-Hinton broth (CAMHB), but reduced in native serum for almost all strains that could grow in this media. In AU MIC values for positive were increased significantly up to 16-fold compared to that in CAMBH, which did not apply to the colistin-susceptible strains tested. Although different growth media could affect the MIC of colistin alone, their impact on the synergistic effect of the combination with the antiviral drug azidothymidine was minimal. The higher divalent cation concentration combined with acidic pH values is most likely responsible for the increased MIC values of the harboring strains tested against colistin in AU compared to that in CAMHB. Antimicrobial susceptibility screening procedures for colistin using CAMHB only could lead to an underestimation of resistance under different physiological conditions. Therefore, not only pharmacokinetic but also pharmacodynamic studies in urine are as important as in serum or plasma.
根据既定指南进行的抗菌药物敏感性测试(AST)对于识别耐药性以及预测特定抗生素治疗的临床成败至关重要。然而,这些指南并未涵盖所有可能对耐药性产生巨大影响的生理状况。在本研究中,我们测试了13株阳性菌株对黏菌素(治疗多重耐药病原体的最后手段抗生素之一)在推荐用于AST的培养基以及在生理上更相关的人血清和人工尿液(AU)中的敏感性。热灭活人血清中的最低抑菌浓度(MIC)值与阳离子调节的 Mueller-Hinton肉汤(CAMHB)中的相似,但对于几乎所有能在此培养基中生长的菌株,其在天然血清中的MIC值降低。在AU中,阳性菌株的MIC值相较于CAMBH显著增加高达16倍,而这不适用于所测试的对黏菌素敏感的菌株。尽管不同的生长培养基可能单独影响黏菌素的MIC,但其对与抗病毒药物齐多夫定联合使用时协同效应的影响最小。与CAMHB相比,较高的二价阳离子浓度与酸性pH值相结合最有可能是导致所测试的携带菌株在AU中对黏菌素的MIC值增加的原因。仅使用CAMHB进行黏菌素的抗菌药物敏感性筛选程序可能会导致在不同生理条件下对耐药性的低估。因此,不仅尿液中的药代动力学研究而且药效学研究与血清或血浆中的研究同样重要。